Five years after the completion of the study, some of its benefits have been maintained
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1 School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, WA.
- 2 Department of Endocrinology and Diabetes, Prince of Wales Hospital, Randwick, NSW.
Correspondence:
- 1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
- 2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
- 3. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-2569.
- 4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
Online responses are no longer available. Please refer to our instructions for authors page for more information.